Oncologic outcomes of segmentectomy for stage IA radiological solid-predominant lung cancer >2 cm in maximum tumour size
Interactive CardioVascular and Thoracic Surgery · 08.11.2022 · 35 (6)
DOI: 10.1093/icvts/ivac246 ↗Kurz gefasst
Fachartikel in der Zeitschrift Interactive CardioVascular and Thoracic Surgery, online erschienen am 26.09.2022. Verfasst von Aritoshi Hattori und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Smoking Research Foundation, National Cancer Center Research and Development Fund.
Abstract (Originalsprache)
OBJECTIVES We aimed to compare the outcomes of segmentectomy with those of lobectomy in clinical-stage IA radiological solid-predominant non-small-cell lung cancer (NSCLC) >2 cm in maximum tumour size. METHODS A retrospective review was performed for radiological solid-predominant NSCLC >2–3 cm in maximum tumour size with a ground-glass opacity component on thin-section computed tomography. Multivariable or propensity score-matched analyses were performed to control for confounders for survival. Overall survival (OS) was analysed using a Kaplan–Meier estimation. RESULTS Of the 215 eligible cases, segmentectomy and lobectomy were performed in 46 and 169 patients. Multivariable analysis revealed that standardized uptake value (hazard ratio: 1.148, 95% confidence interval: 1.032–1.276, P = 0.011) was an independently significant prognosticators of OS, while the operative mode was not associated (hazard ratio: 0.635, 95% confidence interval: 0.132–3.049, P = 0.570). The 5 y-OS was excellent and did not differ significantly between segmentectomy and lobectomy (95.5% vs 90.2%; P = 0.697), which was also shown in the propensity score analysis (96.8% vs 94.0%; P = 0.406), with a median follow-up time of 5.2 years. Locoregional recurrence was found in 2 (4.3%) segmentectomy and 13 (7.7%) lobectomy (P = 0.443). In the subgroup analysis stratified by solid component size, the 5 y-OS was similar between segmentectomy and lobectomy in the c-T1b and c-T1c groups, respectively [c-T1b (n = 163): 94.1% vs 91.8%; P = 0.887 and c-T1c (n = 52): 100% vs 84.9%; P = 0.197]. CONCLUSIONS Segmentectomy showed similar oncological results compared to lobectomy in solid-predominant NSCLC with a ground-glass opacity component >2–3 cm in maximum tumour size. More prospective randomized trials are needed to adequately expand the indication of anatomic segmentectomy for early-stage NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan.
ORCID-Profile: Kazuya Takamochi, Kenji Suzuki
Förderung
- Ministry of Health
- Smoking Research Foundation
- National Cancer Center Research and Development Fund
Zitieren
APA
Hattori, A., Matsunaga, T., Fukui, M., Takamochi, K., Oh, S., & Suzuki, K. (2022). Oncologic outcomes of segmentectomy for stage IA radiological solid-predominant lung cancer >2 cm in maximum tumour size. Interactive CardioVascular and Thoracic Surgery, 35(6). https://doi.org/10.1093/icvts/ivac246
Vancouver
Hattori A, Matsunaga T, Fukui M, Takamochi K, Oh S, Suzuki K. Oncologic outcomes of segmentectomy for stage IA radiological solid-predominant lung cancer >2 cm in maximum tumour size. Interactive CardioVascular and Thoracic Surgery. 2022;35(6). doi:10.1093/icvts/ivac246
BibTeX
@article{Hattori2022,
author = {Hattori, Aritoshi and Matsunaga, Takeshi and Fukui, Mariko and Takamochi, Kazuya and Oh, Shiaki and Suzuki, Kenji},
title = {Oncologic outcomes of segmentectomy for stage IA radiological solid-predominant lung cancer >2 cm in maximum tumour size},
journal = {Interactive CardioVascular and Thoracic Surgery},
year = {2022},
volume = {35},
number = {6},
doi = {10.1093/icvts/ivac246}
}
EUVIMED